Package 33342-106-07

{"route": ["ORAL"], "spl_id": "6330ddef-e7d4-4ec9-a289-4f8acd5f718e", "openfda": {"nui": ["N0000175462", "M0015066", "N0000009947"], "upc": ["0333342106070"], "unii": ["G70B4ETF4S", "OTT9J7900I"], "rxcui": ["476556"], "spl_set_id": ["bc858a35-e0e1-450b-95c3-db3a4fe51a4c"], "pharm_class_cs": ["Nucleosides [CS]"], "pharm_class_epc": ["Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Macleods Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (33342-106-07)", "package_ndc": "33342-106-07", "marketing_start_date": "20200515"}], "brand_name": "Emtricitabine and tenofovir disoproxil fumarate", "product_id": "33342-106_6330ddef-e7d4-4ec9-a289-4f8acd5f718e", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleosides [CS]", "Nucleosides [CS]"], "product_ndc": "33342-106", "generic_name": "Emtricitabine and tenofovir disoproxil fumarate", "labeler_name": "Macleods Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Emtricitabine and tenofovir disoproxil fumarate", "active_ingredients": [{"name": "EMTRICITABINE", "strength": "200 mg/1"}, {"name": "TENOFOVIR DISOPROXIL FUMARATE", "strength": "300 mg/1"}], "application_number": "ANDA203442", "marketing_category": "ANDA", "marketing_start_date": "20200515", "listing_expiration_date": "20261231"}